Kai Rausalu

1.0k total citations
24 papers, 736 citations indexed

About

Kai Rausalu is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Virology. According to data from OpenAlex, Kai Rausalu has authored 24 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Public Health, Environmental and Occupational Health, 14 papers in Infectious Diseases and 5 papers in Virology. Recurrent topics in Kai Rausalu's work include Mosquito-borne diseases and control (18 papers), Viral Infections and Vectors (9 papers) and HIV Research and Treatment (5 papers). Kai Rausalu is often cited by papers focused on Mosquito-borne diseases and control (18 papers), Viral Infections and Vectors (9 papers) and HIV Research and Treatment (5 papers). Kai Rausalu collaborates with scholars based in Estonia, United Kingdom and Finland. Kai Rausalu's co-authors include Andres Merits, Eva Žusinaite, Tero Ahola, Finny S. Varghese, Sirle Saul, Dana L. Vanlandingham, Sazaly Abu Bakar, Keivan Zandi, Stephen Higgs and Age Utt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Scientific Reports.

In The Last Decade

Kai Rausalu

24 papers receiving 728 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Rausalu Estonia 15 433 361 140 110 101 24 736
Thomas Vallet France 11 214 0.5× 252 0.7× 182 1.3× 104 0.9× 26 0.3× 19 658
Ángela Vázquez-Calvo Spain 15 406 0.9× 337 0.9× 216 1.5× 73 0.7× 78 0.8× 40 919
Lucía Carrau United States 12 175 0.4× 348 1.0× 172 1.2× 169 1.5× 32 0.3× 15 757
Abbas El Sahili Singapore 16 324 0.7× 243 0.7× 387 2.8× 51 0.5× 59 0.6× 29 854
Atichat Kuadkitkan Thailand 12 371 0.9× 275 0.8× 158 1.1× 103 0.9× 43 0.4× 18 630
Seok Mui Wang Malaysia 16 743 1.7× 601 1.7× 135 1.0× 83 0.8× 34 0.3× 42 1.1k
Jefree Johari Malaysia 13 349 0.8× 274 0.8× 163 1.2× 40 0.4× 14 0.1× 20 687
Meng‐Hooi Shu Malaysia 10 187 0.4× 144 0.4× 154 1.1× 36 0.3× 16 0.2× 12 474
Santiago Ferrer Spain 21 281 0.6× 241 0.7× 382 2.7× 80 0.7× 10 0.1× 38 999
Carolina Colombelli Pacca Brazil 12 194 0.4× 154 0.4× 69 0.5× 41 0.4× 39 0.4× 25 354

Countries citing papers authored by Kai Rausalu

Since Specialization
Citations

This map shows the geographic impact of Kai Rausalu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Rausalu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Rausalu more than expected).

Fields of papers citing papers by Kai Rausalu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Rausalu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Rausalu. The network helps show where Kai Rausalu may publish in the future.

Co-authorship network of co-authors of Kai Rausalu

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Rausalu. A scholar is included among the top collaborators of Kai Rausalu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Rausalu. Kai Rausalu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Agback, Tatiana, Peter Agback, Vambola Kisand, et al.. (2025). Molecular mechanisms behind the anti corona virus activity of small metal oxide nanoparticles. Nanoscale. 17(7). 3728–3738. 1 indexed citations
2.
Rausalu, Kai, Eva Žusinaite, Vambola Kisand, et al.. (2023). Antiviral efficacy of nanomaterial-treated textiles in real-life like exposure conditions. Heliyon. 9(9). e20067–e20067. 4 indexed citations
3.
Kubo, Anna‐Liisa, Kai Rausalu, Natalja Savest, et al.. (2022). Antibacterial and Antiviral Effects of Ag, Cu and Zn Metals, Respective Nanoparticles and Filter Materials Thereof against Coronavirus SARS-CoV-2 and Influenza A Virus. Pharmaceutics. 14(12). 2549–2549. 23 indexed citations
4.
Rausalu, Kai, Eva Žusinaite, A. S. Vanetsev, et al.. (2022). Antiviral efficacy of cerium oxide nanoparticles. Scientific Reports. 12(1). 18746–18746. 26 indexed citations
5.
Ivanova, Larisa, Kai Rausalu, Eva Žusinaite, et al.. (2021). 1,3-Thiazolbenzamide Derivatives as Chikungunya Virus nsP2 Protease Inhibitors. ACS Omega. 6(8). 5786–5794. 14 indexed citations
6.
Žusinaite, Eva, Liis Karo-Astover, Kai Rausalu, et al.. (2021). Semliki Forest Virus Chimeras with Functional Replicase Modules from Related Alphaviruses Survive by Adaptive Mutations in Functionally Important Hot Spots. Journal of Virology. 95(20). e0097321–e0097321. 5 indexed citations
7.
Lello, Laura Sandra, Age Utt, Koen Bartholomeeusen, et al.. (2020). Cross-utilisation of template RNAs by alphavirus replicases. PLoS Pathogens. 16(9). e1008825–e1008825. 22 indexed citations
8.
Utt, Age, Kai Rausalu, Madis Jakobson, et al.. (2019). Design and Use of Chikungunya Virus Replication Templates Utilizing Mammalian and Mosquito RNA Polymerase I-Mediated Transcription. Journal of Virology. 93(18). 25 indexed citations
9.
Lulla, Valeria, Liis Karo-Astover, Kai Rausalu, et al.. (2018). Timeliness of Proteolytic Events Is Prerequisite for Efficient Functioning of the Alphaviral Replicase. Journal of Virology. 92(14). 20 indexed citations
10.
11.
Mutso, Margit, Sirle Saul, Kai Rausalu, et al.. (2017). Reverse genetic system, genetically stable reporter viruses and packaged subgenomic replicon based on a Brazilian Zika virus isolate. Journal of General Virology. 98(11). 2712–2724. 67 indexed citations
12.
Oo, Adrian, Kai Rausalu, Andres Merits, et al.. (2017). Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection. Antiviral Research. 150. 101–111. 65 indexed citations
13.
Rausalu, Kai, Age Utt, Finny S. Varghese, et al.. (2016). Chikungunya virus infectivity, RNA replication and non-structural polyprotein processing depend on the nsP2 protease’s active site cysteine residue. Scientific Reports. 6(1). 37124–37124. 52 indexed citations
14.
Varghese, Finny S., Bastian Thaa, Siti Naqiah Amrun, et al.. (2016). The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling. Journal of Virology. 90(21). 9743–9757. 111 indexed citations
15.
Varghese, Finny S., Kai Rausalu, Sirle Saul, et al.. (2016). Obatoclax Inhibits Alphavirus Membrane Fusion by Neutralizing the Acidic Environment of Endocytic Compartments. Antimicrobial Agents and Chemotherapy. 61(3). 52 indexed citations
16.
Lani, Rafidah, Pouya Hassandarvish, Ehsan Moghaddam, et al.. (2015). Antiviral activity of silymarin against chikungunya virus. Scientific Reports. 5(1). 11421–11421. 100 indexed citations
17.
Rausalu, Kai, et al.. (2009). Properties and use of novel replication-competent vectors based on Semliki Forest virus. Virology Journal. 6(1). 33–33. 17 indexed citations
18.
Rausalu, Kai, et al.. (2007). CuZn‐SOD suppresses the bovine papillomavirus‐induced proliferation of fibroblasts. Apmis. 115(12). 1409–1414. 1 indexed citations
19.
Sarand, Inga, et al.. (2007). Construction, properties, and potential application of infectious plasmids containing Semliki Forest virus full-length cDNA with an inserted intron. Journal of Virological Methods. 148(1-2). 265–270. 45 indexed citations
20.
Rausalu, Kai, et al.. (2006). Bovine papillomavirus type 1 oncoprotein E5 stimulates the utilization of superoxide radicals in the mouse fibroblast cell line C127. Chemico-Biological Interactions. 159(3). 205–212. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026